NDAQ
50
-6
XRX
52
3
CFG
46
2
ALL
41
6
NRG
37
-2
XEL
53
-2
TROW
50
2
PBI
59
-7
PLD
43
-2
NSC
37
-3
PFG
27
-3
PHM
53
-4
MAT
39
-6
FSLR
63
5
JBHT
53
-3
SCHW
53
-11
MHK
31
-3
EQR
40
-4
AIZ
66
-2
MNST
56
9
NDAQ
50
-6
XRX
52
3
CFG
46
2
ALL
41
6
NRG
37
-2
XEL
53
-2
TROW
50
2
PBI
59
-7
PLD
43
-2
NSC
37
-3
PFG
27
-3
PHM
53
-4
MAT
39
-6
FSLR
63
5
JBHT
53
-3
SCHW
53
-11
MHK
31
-3
EQR
40
-4
AIZ
66
-2
MNST
56
9
Financhill
Back

BioStem Technologies 10K Form

Buy
63

BSEM
BioStem Technologies

Last Price:
17.21
Seasonality Move:
-4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BSEM News And Ratings

See the #1 stock for the next 7 days that we like better than BSEM

BSEM Financial Statistics

Sales & Book Value

Annual Sales: $6.88M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-0.26
Price / Book: 0

Profitability

EPS (TTM): -0.48000
Net Income (TTM): $-5.74M
Gross Margin: $5.99M
Return on Equity: 0%
Return on Assets: -139.02%

BioStem Technologies Earnings Forecast

Key BioStem Technologies Financial Ratios

  • The Gross Profit Margin over the past 11 years for BSEM is 87.17%.
  • The Selling, General & Administrative Expenses for BSEM have been equal to 151.73% of Gross Profit Margin.
  • The Interest Expense is -6.62% of Operating Income.
  • The Net Earning history of BSEM is -102.90% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

BioStem Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BSEM
Website: biostemtechnologies.com

Debt

Debt-to-Equity Ratio: -1.7
Current Ratio: 0.48
Quick Ratio: 0.38

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BSEM Technical Analysis vs Fundamental Analysis

Buy
63
BioStem Technologies (BSEM) is a Buy

Is BioStem Technologies a Buy or a Sell?